Innovative Medicines Canada warns new pricing regulations will limit patient access to new medicines and discourage investment

August 9, 2019

Ottawa, August 9, 2019—Innovative Medicines Canada (IMC) warns that the amendments to the Patented Medicine Prices Review Board’s (PMPRB) Regulations announced today will limit Canadian patients’ access to new innovative […]

IMC responds to final report of Advisory Council on the Implementation of National Pharmacare

June 12, 2019

The recommendations put forward today […]

Innovative Medicines Canada disappointed by British Columbia government’s move to limit patient choice and access to therapies

June 3, 2019

Ottawa, June 3, 2019 – Innovative Medicines Canada (IMC) expressed its disappointment in the Government of British Columbia’s recent decision to force patients to switch from originator biologic therapies to […]

Quebec Budget 2019-2020: Innovative Medicines Canada welcomes investments in R&D and artificial intelligence

March 21, 2019

Montreal, March 21, 2019 – In response to the budget tabled by Quebec’s Finance Minister, Éric Girard, Innovative Medicines Canada (IMC) welcomes the first budget of the new Quebec government, […]

Budget 2019: Collaboration is essential to success of national pharmacare

March 19, 2019

IMC welcomes the measures taken in Budget 2019 […]

Fiscal Update 2018: Innovative Medicines Canada welcomes renewed commitment to competitiveness

November 21, 2018

Ottawa, November 21, 2018 The following statement can be attributed to Innovative Medicines Canada President, Pamela Fralick. “As a driver of innovation, the innovative pharmaceutical industry welcomes the targeted measures […]

Innovative Medicines Canada welcomes ISED roundtable recommendations for health & biosciences sector

September 25, 2018

IMC welcomes ISED roundtable recommendations […]

Innovative Medicines Canada applauds the changes to OHIP+

July 3, 2018

Ottawa, July 3, 2018 –  Innovative Medicines Canada congratulates the new Ontario Minister of Health and Long-Term Care, Christine Elliott, on moving decisively to revamp OHIP+. “It’s a win-win for […]

Statement: National pharmacare should ensure access to medicines for all

April 19, 2018

Ottawa, April 19, 2018 –  The following statement can be attributed to Pamela Fralick, President, Innovative Medicines Canada. “Innovative Medicines Canada agrees with the House of Commons Standing Committee on […]

Statement: Code of Ethical Practices

April 12, 2018

Ottawa, April 12, 2018 – The following statement can be attributed to Pamela Fralick, President, Innovative Medicines Canada. “All members of Innovative Medicines Canada are bound by the association’s Code of […]